The latest generation of leadless pacemakers is able to provide atrio-ventricular synchrony (AVS). The performance of these devices regarding ambulant AVS is still under debate. In an analysis by Garweg and co-authors, the AM-VP device counter was considered a reliable marker for true AVS and outpatient AVS in a large cohort was estimated to be ~75%. This editorial critically reflects the findings of Garweg et al. In general, evidence is increasing that leadless pacemakers with mechanical sensing provide an adequate degree of AVS in the outpatient setting. Device counters may indeed help to better understand specific programming-related challenges, but important questions regarding their diagnostic accuracy remain. This article is protected...
BackgroundCardiac Implantable Electronic Device infections increase short- and long-term mortality, ...
AbstractIntroductionThe incidence of pacemaker-mediated tachycardia (PMT) varies as a function of pa...
ObjectiveAutomatic algorithms in pacemakers (PM) allow continuous adaptation of settings to patients...
The latest generation of leadless pacemakers is able to provide atrio-ventricular synchrony (AVS). T...
Since the arrival of leadless pacemakers (LPs), they have become a cornerstone in remedial treatment...
© 2020 The Authors Objectives: This study reports on the performance of a leadless ventricular pacem...
Despite continuous technological developments, transvenous pacemakers (PM) are still associated with...
BACKGROUND: Micra is a leadless pacemaker that is implanted in the right ventricle and provides rate...
BACKGROUND Leadless pacemakers (PMs) capable of atrio-ventricular (AV) synchronous pacing have re...
BACKGROUND: The MARVEL (Micra Atrial TRacking Using a Ventricular AccELerometer) 2 study assessed th...
Leadless or transcatheter pacemakers have recently been introduced to market with important benefits...
Introduction: The incidence of pacemaker-mediated tachycardia (PMT) varies as a function of patient ...
Leadless pacemakers (LLPMs) have become a major breakthrough in the management of bradyarrhythmia a...
Since the first successful pacemaker implantation in 1958, pacing remains the only reliable treatmen...
Background: The hemodynamic advantages of maintaining AV synchrony through AV synchronou...
BackgroundCardiac Implantable Electronic Device infections increase short- and long-term mortality, ...
AbstractIntroductionThe incidence of pacemaker-mediated tachycardia (PMT) varies as a function of pa...
ObjectiveAutomatic algorithms in pacemakers (PM) allow continuous adaptation of settings to patients...
The latest generation of leadless pacemakers is able to provide atrio-ventricular synchrony (AVS). T...
Since the arrival of leadless pacemakers (LPs), they have become a cornerstone in remedial treatment...
© 2020 The Authors Objectives: This study reports on the performance of a leadless ventricular pacem...
Despite continuous technological developments, transvenous pacemakers (PM) are still associated with...
BACKGROUND: Micra is a leadless pacemaker that is implanted in the right ventricle and provides rate...
BACKGROUND Leadless pacemakers (PMs) capable of atrio-ventricular (AV) synchronous pacing have re...
BACKGROUND: The MARVEL (Micra Atrial TRacking Using a Ventricular AccELerometer) 2 study assessed th...
Leadless or transcatheter pacemakers have recently been introduced to market with important benefits...
Introduction: The incidence of pacemaker-mediated tachycardia (PMT) varies as a function of patient ...
Leadless pacemakers (LLPMs) have become a major breakthrough in the management of bradyarrhythmia a...
Since the first successful pacemaker implantation in 1958, pacing remains the only reliable treatmen...
Background: The hemodynamic advantages of maintaining AV synchrony through AV synchronou...
BackgroundCardiac Implantable Electronic Device infections increase short- and long-term mortality, ...
AbstractIntroductionThe incidence of pacemaker-mediated tachycardia (PMT) varies as a function of pa...
ObjectiveAutomatic algorithms in pacemakers (PM) allow continuous adaptation of settings to patients...